Clinical Insights
home
contact
about usprincipal investigatorclinical trialsinterest formdirections
About Us
Clinical Trials ExperienceAssessment ExperiencePharmaceutical Sponsors

Clinical Trials Experience

2006

  • A Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Study Drug Versus Placebo as Adjunct Therapy with Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients with Bipolar I Disorder

  • A Six-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible Doses of Study Drug in Outpatients with Bipolar I Disorder

  • A Multicenter, Double-Blind, Randomized-Withdrawal, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Study Drug as Monotherapy in the Maintenance Treatment of Patients with Major Depressive Disorder Following an Open-Label Stabilization Period

  • A Multicenter, Double-Blind, Study on the Efficacy and Safety of Study Drug in Combination with Study Drug in the Long-Term Maintenance Treatment of Patients with Bipolar I Disorder with a Recent Manic or Mixed Episode

  • Efficacy, Safety and Tolerability of Study Drug in the Treatment of Children Aged 6 to 17 Years with ADHD-Associated Insomnia. A Multicentre, Randomized, Double-Blind, Placebo Controlled Study

Clinical Insights
Clinical Insights
Clinical Insights 1600 Crain Highway South - Suite 601 - Glen Burnie, MD 21061 - 410.768.2629 Clinical Insights 1600 Crain Highway South - Suite 601 - Glen Burnie, MD 21061 - 410.768.2629